135 related articles for article (PubMed ID: 32960216)
1. Separate and not equal: sex differences in JAM-A tumor suppression in glioblastoma.
Shireman JM; Ahmed AU
Neuro Oncol; 2020 Nov; 22(11):1555-1556. PubMed ID: 32960216
[No Abstract] [Full Text] [Related]
2. JAM-A functions as a female microglial tumor suppressor in glioblastoma.
Turaga SM; Silver DJ; Bayik D; Paouri E; Peng S; Lauko A; Alban TJ; Borjini N; Stanko S; Naik UP; Keri RA; Connor JR; Barnholtz-Sloan JS; Rubin JB; Berens M; Davalos D; Lathia JD
Neuro Oncol; 2020 Nov; 22(11):1591-1601. PubMed ID: 32592484
[TBL] [Abstract][Full Text] [Related]
3. Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma.
Kfoury N; Qi Z; Prager BC; Wilkinson MN; Broestl L; Berrett KC; Moudgil A; Sankararaman S; Chen X; Gertz J; Rich JN; Mitra RD; Rubin JB
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33850013
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
[TBL] [Abstract][Full Text] [Related]
5. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
[TBL] [Abstract][Full Text] [Related]
6. Integrative multi-omics characterization reveals sex differences in glioblastoma.
Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
[TBL] [Abstract][Full Text] [Related]
7. Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
PLoS One; 2019; 14(5):e0217785. PubMed ID: 31150499
[TBL] [Abstract][Full Text] [Related]
8. Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.
Sun T; Warrington NM; Luo J; Brooks MD; Dahiya S; Snyder SC; Sengupta R; Rubin JB
J Clin Invest; 2014 Sep; 124(9):4123-33. PubMed ID: 25083989
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.
Bayik D; Zhou Y; Park C; Hong C; Vail D; Silver DJ; Lauko A; Roversi G; Watson DC; Lo A; Alban TJ; McGraw M; Sorensen M; Grabowski MM; Otvos B; Vogelbaum MA; Horbinski C; Kristensen BW; Khalil AM; Hwang TH; Ahluwalia MS; Cheng F; Lathia JD
Cancer Discov; 2020 Aug; 10(8):1210-1225. PubMed ID: 32300059
[TBL] [Abstract][Full Text] [Related]
10. Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.
Lee J; Troike K; Fodor R; Lathia JD
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35023543
[TBL] [Abstract][Full Text] [Related]
11. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.
Schiffgens S; Wilkens L; Brandes AA; Meier T; Franceschi E; Ermani M; Hartmann C; Sandalcioglu IE; Dumitru CA
Oncotarget; 2016 Aug; 7(34):55169-55180. PubMed ID: 27409829
[TBL] [Abstract][Full Text] [Related]
13. Sex-Specific Differences in Glioblastoma.
Carrano A; Juarez JJ; Incontri D; Ibarra A; Guerrero Cazares H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359952
[TBL] [Abstract][Full Text] [Related]
14. The crucial role of DNA-dependent protein kinase and myelin transcription factor 1-like protein in the miR-141 tumor suppressor network.
Wang B; Li D; Yao Y; Heyns M; Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Bronson RT; Metz GAS; Kovalchuk O; Kovalchuk I
Cell Cycle; 2019 Nov; 18(21):2876-2892. PubMed ID: 31522595
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 14q may harbor multiple tumor suppressor genes in primary glioblastoma multiforme.
Hu J; Jiang C; Ng HK; Pang JC; Tong CY
Chin Med J (Engl); 2002 Aug; 115(8):1201-4. PubMed ID: 12215292
[TBL] [Abstract][Full Text] [Related]
16. GATA4 and DcR1 methylation in glioblastomas.
Vaitkienė P; Skiriutė D; Skauminas K; Tamašauskas A
Diagn Pathol; 2013 Jan; 8():7. PubMed ID: 23320456
[TBL] [Abstract][Full Text] [Related]
17. Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.
Nawaz Z; Patil V; Thinagararjan S; Rao SA; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Oncol; 2017 Aug; 11(8):927-944. PubMed ID: 28378523
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
[TBL] [Abstract][Full Text] [Related]
19. LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor.
Guo D; Yang H; Guo Y; Xiao Q; Mao F; Tan Y; Wan X; Wang B; Lei T
J Neurol Sci; 2015 Mar; 350(1-2):61-8. PubMed ID: 25708990
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
